Relative influence of antibiotic therapy attributes on physician choice in treating acute uncomplicated pyelonephritis

Medical Decision Making

Volumn 27, Issue 4, 2007, Pages 387-394

  McGregor, Jessina C ^a,c   Harris, Anthony D ^a   Furuno, Jon P ^a   Bradham, Douglas D ^a,b   Perencevich, Eli N ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c OREGON STATE UNIVERSITY   (United States)

Author keywords

Antibacterial agents administration and dosage; Choice behavior; Decision making; Pyelonephritis; Questionnaires; Urinary tract infection

Indexed keywords

ANTIBIOTIC AGENT;

ACUTE PYELONEPHRITIS; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE DURATION; DOSAGE SCHEDULE COMPARISON; DRUG DOSE REGIMEN; DRUG TREATMENT FAILURE; FREQUENCY ANALYSIS; HUMAN; MATHEMATICAL MODEL; PHYSICIAN; PHYSICIAN ATTITUDE; PREDICTION; PROPORTIONAL HAZARDS MODEL; QUANTITATIVE ANALYSIS; QUESTIONNAIRE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TREATMENT INDICATION;

ACUTE DISEASE; ANTI-BACTERIAL AGENTS; DECISION MAKING; DRUG ADMINISTRATION SCHEDULE; HUMANS; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PYELONEPHRITIS; QUESTIONNAIRES;

EID: 34547131576     PISSN: 0272989X     EISSN: 1552681X     Source Type: Journal    
DOI: 10.1177/0272989X07302556     Document Type: Article

References (33)

1. Shlaes DM, Gerding DN, John JF Jr, et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Infect Control Hosp Epidemiol. 1997 ; 18: 275 - 91.
2. Alliance for the Prudent Use of Antibiotics. Antibiotic Resistance: Synthesis of Recommendations by Expert Policy Groups. Geneva, Switzerland: World Health Organization; 2001. Available at: URL: http://www.who.int/ drugresistance/Antimicrobial_resistance_recommendations_of_expert_polic.pdf.
3. National Center for Infectious Diseases Division of Bacterial and Mycotic Diseases. CDC Get Smart Website. Available at: URL: www.cdc.gov/getsmart. Accessed 11 August 2005.
4. Slama TG, Amin A., Brunton SA, et al. A clinician's guide to the appropriate and accurate use of antibiotics: the Council for Appropriate and Rational Antibiotic Therapy (CARAT) criteria. Am J Med. 2005 ; 118: 1S - 6S.
5. Liu H., Mulholland SG Appropriate antibiotic treatment of genitourinary infections in hospitalized patients. Am J Med. 2005 ; 118: 14S - 20S.
6. David RD, DeBlieux PM, Press R. Rational antibiotic treatment of outpatient genitourinary infections in a changing environment. Am J Med. 2005 ; 118: 7S - 13S.
7. Warren JW, Abrutyn E., Hebel JR, Johnson JR, Schaeffer AJ, Stamm WE Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis. 1999 ; 29: 745 - 58.
8. Milo G., Katchman EA, Paul M., Christiaens T., Baerheim A., Leibovici L. Duration of antibacterial treatment for uncomplicated urinary tract infection in women. Cochrane Database Syst Rev. 2005 ;(2). CD004682.
9. Stamm WE Urinary tract infections and pyelonephritis. In: Kasper DL, Harrison TR, eds. Harrison's Principles of Internal Medicine. New York: McGraw-Hill ; 2005. p 1715 - 21.
10. Stamm WE, Hooton TM Management of urinary tract infections in adults. N Engl J Med. 1993 ; 329: 1328 - 34.
11. Talan DA, Stamm WE, Hooton TM, et al. Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis in women: a randomized trial. JAMA. 2000 ; 283: 1583 - 90.
12. Bailey RR Duration of antimicrobial treatment and the use of drug combinations for the treatment of uncomplicated acute pyelonephritis. Infection. 1994 ; 22 (suppl 1). S50 - 2.
13. Bailey RR, Peddie BA Treatment of acute urinary tract infection in women. Ann Intern Med. 1987 ; 107: 430.
14. Stamm WE, Hooton TM, Johnson JR, et al. Urinary tract infections: from pathogenesis to treatment. J Infect Dis. 1989 ; 159: 400 - 6.
15. Kuhfeld WF Marketing Research Methods in SAS: Experimental Design, Choice, Conjoint, and Graphical Techniques. Cary, NC: SAS Institute ; 2003.
16. Ryan M. Using conjoint analysis to take account of patient preferences and go beyond health outcomes: an application to in vitro fertilisation. Soc Sci Med. 1999 ; 48: 535 - 46.
17. Louviere JJ Analyzing Decision Making: Metric Conjoint Analysis. Newbury Park, CA: Sage ; 1988.
18. Hensher DA, Johnson LW Applied Discrete-Choice Modelling. London: Croom Helm, Wiley ; 1981.
19. Pearmain D., Swanson J., Kroes E., Bradley M. Stated Preference Techniques: A Guide to Practice. Hague, The Netherlands: Steer Davis Gleave and Hague Consulting Group ; 1991.
20. Harrell FE Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis. New York: Springer; 2001.
21. Allison PD, SAS Institute. Survival Analysis Using the SAS System: A Practical Guide. Cary, NC: SAS Institute; 1995.
22. Breslow N. Covariance analysis of censored survival data. Biometrics. 1974 ; 30: 89 - 99.
23. Perencevich EN, Kaye KS, Strausbaugh LJ, Fisman DN, Harris AD Acceptable rates of treatment failure in osteomyelitis involving the diabetic foot: a survey of infectious diseases consultants. Clin Infect Dis. 2004 ; 38: 476 - 82.
24. Perencevich EN, Harris AD, Kaye KS, et al. Physicians' acceptable treatment failure rates in antibiotic therapy for coagulasenegative staphylococcal catheter-associated bacteremia: implications for reducing treatment duration and antibiotic exposure. Clin Infect Dis. 2005 ; 41: 1734 - 41.
25. Aristides M., Chen J., Schulz M., Williamson E., Clarke S., Grant K. Conjoint analysis of a new chemotherapy: willingness to pay and preference for the features of raltitrexed versus standard therapy in advanced colorectal cancer. Pharmacoeconomics. 2002 ; 20: 775 - 84.
26. Ratcliffe J., Buxton M., McGarry T., Sheldon R., Chancellor J. Patients' preferences for characteristics associated with treatments for osteoarthritis. Rheumatology (Oxford). 2004 ; 43: 337 - 45.
27. Flach SD, Diener A. Eliciting patients' preferences for cigarette and alcohol cessation: an application of conjoint analysis. Addict Behav. 2004 ; 29: 791 - 9.
28. Bryan S., Buxton M., Sheldon R., Grant A. Magnetic resonance imaging for the investigation of knee injuries: an investigation of preferences. Health Econ. 1998 ; 7: 595 - 603.
29. Metlay JP, Shea JA, Crossette LB, Asch DA Tensions in antibiotic prescribing: pitting social concerns against the interests of individual patients. J Gen Intern Med. 2002 ; 17: 87 - 94.
30. Bell RA, Kravitz RL, Thom D., Krupat E., Azari R. Unmet expectations for care and the patient-physician relationship. J Gen Intern Med. 2002 ; 17: 817 - 24.
31. Butler CC, Rollnick S., Pill R., Maggs-Rapport F., Stott N. Understanding the culture of prescribing: qualitative study of general practitioners' and patients' perceptions of antibiotics for sore throats. BMJ. 1998 ; 317: 637 - 42.
32. Britten N., Ukoumunne O. The influence of patients' hopes of receiving a prescription on doctors' perceptions and the decision to prescribe: a questionnaire survey. BMJ. 1997 ; 315: 1506 - 10.
33. Little P., Dorward M., Warner G., Stephens K., Senior J., Moore M. Importance of patient pressure and perceived pressure and perceived medical need for investigations, referral, and prescribing in primary care: nested observational study. BMJ. 2004 ; 328: 444.